Equities Feed
BioDelivery Sciences International, Inc. (BDSI) Stock Up in the Premarket, Here’s What’s Happening.
BioDelivery Sciences International, Inc. (BDSI) is engaged in the commercialization of therapeutics for patients with chronic conditions. The company has a versatile portfolio of differentiated pain and neurology product line. The company’s pipeline product portfolio includes treatments for chronic pain, acute migraine, and opioid-induced constipation.
